Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has issued an announcement.
China Shineway Pharmaceutical Group Limited has declared a first interim ordinary dividend of RMB 0.43 per share for the fiscal year ending 31 December 2026, equivalent to HKD 0.487 per share based on an exchange rate of RMB 1 to HKD 1.132. The move underscores the company’s continued commitment to shareholder returns, with the ex-dividend date set for 4 May 2026, a record date of 7 May 2026, and payment scheduled for 19 May 2026 through its Hong Kong share registrar.
The announced dividend timetable, including a book closure period from 6 to 7 May 2026 and no applicable withholding tax, provides clear visibility for investors on entitlement and cash flow expectations. This early interim payout for the 2026 fiscal year signals confidence from the board in the company’s financial position and cash generation, reinforcing its profile as a yield-oriented stock in the Hong Kong pharmaceutical sector.
The most recent analyst rating on (HK:2877) stock is a Buy with a HK$11.00 price target. To see the full list of analyst forecasts on China Shineway Pharmaceutical Group Limited stock, see the HK:2877 Stock Forecast page.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is a Hong Kong-listed pharmaceutical company focused on producing and distributing medicinal products in the China market. The group operates within the broader healthcare and pharmaceuticals industry and serves shareholders through regular cash dividend distributions in Hong Kong dollars.
Average Trading Volume: 967,293
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.65B
See more data about 2877 stock on TipRanks’ Stock Analysis page.